Evidence map›Paper›PMID 41123620›Full record

ArticleHerzschrittmachertherapie & Elektrophysiologie2025

Supplementary case reports to the current German Cardiac Society (DGK) position paper on electrical cardioversion : Cardioversion-resistant atrial fibrillation in obese patients: a therapeutic dead-end? Synchronized cardioversion-induced ventricular fibrillation: an uncommon complication.

Nawar Alhourani, Felix Wegner, Fatih Güner, Lars Eckardt

Abstract readCase ReportsConsensus Statement
In one paragraph

Article in Herzschrittmachertherapie & Elektrophysiologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nawar AlhouraniDepartment of Cardiology II: Electrophysiology, University Hospital Münster, Albert-Schweitzer Campus 1, 48149, Münster, Germany. nawar.alhourani@ukmuenster.de.ORCID http://orcid.org/0009-0006-1007-6705
Felix WegnerDepartment of Cardiology II: Electrophysiology, University Hospital Münster, Albert-Schweitzer Campus 1, 48149, Münster, Germany.
Fatih GünerDepartment of Cardiology II: Electrophysiology, University Hospital Münster, Albert-Schweitzer Campus 1, 48149, Münster, Germany.
Lars EckardtDepartment of Cardiology II: Electrophysiology, University Hospital Münster, Albert-Schweitzer Campus 1, 48149, Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electrical cardioversion represents a cornerstone of rhythm control strategies in patients with atrial fibrillation. However, in patients with obesity and specific anatomical variations, e.g. post heart transplantation, the standard flow of this procedure may need to be altered. This includes employing technical deviations of shock delivery and paying special attention to potential, unexpected complications. In light of the current position paper of the German Cardiac Society (Deutsche Gesellschaft für Kardiologie, DGK) on electrical cardioversion of atrial fibrillation, two cases with unconventional course of elective electrical cardioversion of atrial fibrillation are presented: dual direct current cardioversion in severe obesity and the occurrence of ventricular fibrillation in the presence of heterotopic heart transplant.

Indexed as

Atrial FibrillationElectric CountershockObesityVentricular FibrillationFemaleGermanyHumansMaleMiddle AgedTreatment OutcomeAtrial fibrillationDual simultaneous cardioversionHeterotopic heart transplantObesityVentricular fibrillation

Identifiers

PMID41123620
PMCPMC12638371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.